Innate Pharma
(IPHYF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,847 | 76,416 | 88,740 | 122,754 | 156,258 |
| Marketable Securities | 15,554 | 23,649 | 18,185 | 19,024 | 16,957 |
| Receivables | 5,380 | 60,129 | 40,401 | 21,793 | 24,918 |
| Other current assets | 0 | -1 | 0 | 0 | 0 |
| TOTAL | $92,781 | $160,193 | $147,326 | $163,571 | $198,133 |
| Non-Current Assets | |||||
| PPE Net | 5,554 | 6,842 | 9,000 | 12,037 | 13,358 |
| Intangibles | 0 | 450 | 1,639 | 52,284 | 52,876 |
| Other Non-Current Assets | 21,841 | 31,866 | 61,040 | 88,585 | 86,802 |
| TOTAL | $27,396 | $39,159 | $71,680 | $152,905 | $153,036 |
| Total Assets | $120,177 | $199,352 | $219,005 | $316,475 | $351,169 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,321 | 18,419 | 22,032 | 33,805 | 33,742 |
| Other current liabilities | 17,702 | 18,133 | 14,610 | 45,920 | 5,312 |
| TOTAL | $35,690 | $42,899 | $43,554 | $94,513 | $51,961 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 667 | 6,348 | 6,912 | 14,789 | 12,907 |
| Other Non-Current Liabilities | 71,871 | 85,535 | 101,024 | 58,833 | 75,617 |
| TOTAL | $74,928 | $100,281 | $118,397 | $94,848 | $121,036 |
| Total Liabilities | $110,618 | $143,180 | $161,951 | $189,361 | $172,998 |
| Shareholders' Equity | |||||
| Common Shares | 4,536 | 4,377 | 4,226 | 4,706 | 4,512 |
| Retained earnings | -364,552 | -356,426 | -286,804 | -259,577 | -178,743 |
| Other shareholders' equity | -53,503 | -7,657 | -60,354 | -61,940 | -72,683 |
| TOTAL | $9,559 | $56,173 | $57,054 | $127,112 | $178,171 |
| Total Liabilities And Equity | $120,177 | $199,352 | $219,005 | $316,473 | $351,169 |